Boston Scientific Will Buy Cameron Health

Boston Scientific has announced plans to acquire Cameron Health. Boston Scientific will initially shell out $150 in cash for the deal, with up to $1.2 billion more to come if Cameron's defibrillator product meets regulatory and sales expectations, Reuters reports.

The S-ICD can be placed beneath the skin as opposed to inside the heart and uses a signal similar to an ECG to monitor the heart for signs of cardiac arrest.

The device has already received a CE mark in Europe, where it has been sold since 2009. Boston Scientific anticipates the S-ICD will receive approval in the U.S. somtime next year, according to Reuters. Cameron submitted a PMA application for the device in January.


Jamie Hartford is associate editor of MED. @readMED


Related Content

Boston Scientific CEO to Congress: Repeal the Device Tax Now

Boston Scientific CEO to Resign

Smaller, Thinner CRT-Ds and ICDs